Skip to main content
. 2023 Mar 27;46(3):133–141. doi: 10.14348/molcells.2023.0028

Fig. 1. Therapeutic strategies to control NRF2-overeactivated cancers.

Fig. 1

In the tumor, NRF2 inhibitors help suppress tumor growth and metastasis by decreasing NRF2 protein levels. In addition, synthetic lethality anti-cancer drugs are transformed into strongly active drugs by NRF2-targeted drug-metabolizing enzymes. In contrast, activation of NRF2 in the microenvironment inhibits the progression of NRF2-overactivated malignant tumors. NRF2, NF-E2-related factor 2.